<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01312727</url>
  </required_header>
  <id_info>
    <org_study_id>P081258</org_study_id>
    <nct_id>NCT01312727</nct_id>
  </id_info>
  <brief_title>Hereditary Tubulointerstitial Nephritis</brief_title>
  <acronym>NTIH</acronym>
  <official_title>Phenotypical and Genetic Characterization of Adult Hereditary Chronic Tubulointerstitial Renal Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to identify families with hereditary chronic tubulointerstitial
      renal diseases , characterize the phenotype and screen for mutations in known genesis (UMOD,
      REN, TCF2, NPHP1). Genome wide analysis will be performed in families without mutations
      identified.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Inclusion of affected subjects with familial history of chronic renal failure, early
           gout ,renal cysts in several hospital in France

        -  Characterization of the phenotype; dosage of the urinary uromodulin in all subjects

        -  Collect DNA samples

        -  Screen for UMO mutations first

        -  Then for REN or TCF2 depending on the phenotype

        -  Validate the use of the dosage of urinary uromodulin for the diagnosis of UMOD
           associated disease.

        -  Identify new genes responsible for hereditary HTIN (Hereditary Tubulointerstitial
           Nephritis).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">February 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Genotype of HTIN</measure>
    <time_frame>after 18 months</time_frame>
    <description>Number of patients/families with mutations in known genes responsible for HTIN</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Uromodulin dosage in urine</measure>
    <time_frame>at 18 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">225</enrollment>
  <condition>Nephritis, Interstitial</condition>
  <condition>Chronic Renal Failure</condition>
  <condition>Gout</condition>
  <condition>Renal Cysts</condition>
  <arm_group>
    <arm_group_label>HTIN</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>HTIN</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood and urine sample collections</intervention_name>
    <description>phenotype and genotype analysis, biological analysis</description>
    <arm_group_label>HTIN</arm_group_label>
    <other_name>phenotype and genotype analysis, biological analysis</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 18 years.

          -  HTIN of unknown cause

          -  Chronic renal failure defined by a eGFR (estimated Glomerular Filtration Rate)
             estimated according to MDRD (Modification of the Diet in Renal Disease) &lt; 60ml / min /
             1,73m2.

          -  At least two siblings affected by gout before 40 years or by chronic renal failure.

          -  Affiliated or benefiting from a national insurance

          -  Signature of the enlightened consent.

        Exclusion Criteria:

          -  Endstage renal failure before the age of 18 years in all affected subjects of the
             family.

          -  Microscopic or macroscopic persistent hematuria, or proteinuria &gt; 1gramme / 24hours.

          -  Other potential cause of TIN (Tubulointerstitial Nephritis): pyelonephritis, drug
             toxicity.

          -  High blood pressure known for more than 10 years before the discovery of the renal
             disease.

          -  Major cardiovascular before the discovery of the renal disease.

          -  Chronic auto-immune or infectious disease.

          -  Polycystic kidney disease with increased of the size of the kidneys
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bertrand Knebelmann, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital Necker Enfants Malades</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 22, 2011</study_first_submitted>
  <study_first_submitted_qc>March 9, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 11, 2011</study_first_posted>
  <last_update_submitted>August 25, 2016</last_update_submitted>
  <last_update_submitted_qc>August 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Tubulointerstitial renal diseases</keyword>
  <keyword>Hereditary renal diseases</keyword>
  <keyword>Uromodulin</keyword>
  <keyword>Renin gene</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Nephritis</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
    <mesh_term>Nephritis, Interstitial</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

